The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Survey of prenatal screening policies in Europe for structural malformations and chromosome anomalies, and their impact on detection and termination rates for neural tube defects and Down’s syndrome
Open accessAbstract
Objective To ‘map’ the current (2004) state of prenatal screening in Europe. Design (i) Survey of country policies and (ii) analysis of data from EUROCAT (European Surveillance of Congenital Anomalies) population‐based congenital anomaly registers. Setting Europe. Population Survey of prenatal screening policies in 18 countries and 1.13 million births in 12 countries in 2002–04. Methods (i) Questionnaire on national screening policies and termination of pregnancy for fetal anomaly (TOPFA) laws in 2004. (ii) Analysis of data on prenatal detection and termination for Down’s syndrome and neural tube defects (NTDs) using the EUROCAT database. Main outcome measures Existence of national prenatal screening policies, legal gestation limit for TOPFA, prenatal detection and termination rates for Down’s syndrome and NTD. Results Ten of the 18 countries had a national country‐wide policy for Down’s syndrome screening and 14/18 for structural anomaly scanning. Sixty‐eight percent of Down’s syndrome cases (range 0–95%) were detected prenatally, of which 88% resulted in termination of pregnancy. Eighty‐eight percent (range 25–94%) of cases of NTD were prenatally detected, of which 88% resulted in termination. Countries with a first‐trimester screening policy had the highest proportion of prenatally diagnosed Down’s syndrome cases. Countries with no official national Down’s syndrome screening or structural anomaly scan policy had the lowest proportion of prenatally diagnosed Down’s syndrome and NTD cases. Six of the 18 countries had a legal gestational age limit for TOPFA, and in two countries, termination of pregnancy was illegal at any gestation. Conclusions There are large differences in screening policies between countries in Europe. These, as well as organisational and cultural factors, are associated with wide country variation in prenatal detection rates for Down’s syndrome and NTD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
First-Trimester or Second-Trimester Screening, or Both, for Down's Syndrome
Malone, F. D., Canick, J. A., Ball, R. H., Nyberg, D. A., Comstock, C. H., Bukowski, R. K., Berkowitz, R. L., Gross, S. J., Dugoff, L., Craigo, S., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043693 · Cited by 1,073
Detection of Transposition of the Great Arteries in Fetuses Reduces Neonatal Morbidity and Mortality
Bonnet, D., Coltri, A., Butera, G., Fermont, L., Le Bidois, J., Kachaner, J., & Sidi, D. (1999) · Circulation · doi:10.1161/01.cir.99.7.916 · Cited by 760
First-Trimester Screening for Trisomies 21 and 18
Wapner, R. J., Thom, E. A., Simpson, J. L., Pergament, E., Silver, R. K., Filkins, K. A., Platt, L. D., Mahoney, M., Johnson, A., Hogge, W. A., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa025273 · Cited by 559
Wald, N., Watt, H., & Hackshaw, A. K. (1999) · New England Journal of Medicine · doi:10.1056/nejm199908123410701 · Cited by 525
Antenatal Screening for Down's Syndrome
Wald, N., Kennard, A., Hackshaw, A. K., & McGuire, A. (1997) · Journal of Medical Screening · doi:10.1177/096914139700400402 · Cited by 434
Plasma placental RNA allelic ratio permits noninvasive prenatal chromosomal aneuploidy detection
Lo, Y. M. D., Tsui, N. B. Y., Chiu, R. W. K., Lau, T. K., Leung, T. N., Heung, M. M. S., Gerovassili, A., Jin, Y., Nicolaides, K. H., Cantor, C. R., et al. (2007) · Nature Medicine · doi:10.1038/nm1530 · Cited by 377
Khoshnood, B., De Vigan, C., Vodovar, V., Goujard, J., Lhomme, A., Bonnet, D., & Goffinet, F. (2005) · Pediatrics · doi:10.1542/peds.2004-0516 · Cited by 302
Self-citationPrenatal diagnosis and selective abortion: a challenge to practice and policy.
Asch, A. (1999) · American Journal of Public Health · doi:10.2105/ajph.89.11.1649 · Cited by 264
Dhallan, R., Guo, X., Emche, S., Damewood, M. D., Bayliss, P., Cronin, M., Barry, J., Betz, J. F., Franz, K., Gold, K., et al. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60115-9 · Cited by 201
Choice of effect measure for epidemiological data
Walter, S. D. (2000) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(00)00210-9 · Cited by 193
Research works printed but not linked: 1
- Leschot NJ, 1997, Prenatal Diagnosis in Europe, Eur J Hum Genet, 5
Cited by
Sorted by citations
Congenital Heart Defects in Europe
Dolk, H. M., Loane, M. A., Garne, E., & a European Surveillance of Congenital Anomalies (EUROCAT) Working Group (2011) · Circulation · doi:10.1161/circulationaha.110.958405 · Cited by 962
Self-citationThe Prevalence of Congenital Anomalies in Europe
Dolk, H. M., Loane, M. A., & Garne, E. (2010) · Advances in experimental medicine and biology · doi:10.1007/978-90-481-9485-8_20 · Cited by 718
Self-citationComplicated grief after perinatal loss
Kersting, A., & Wagner, B. (2012) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2012.14.2/akersting · Cited by 419
Update on Procedure-Related Risks for Prenatal Diagnosis Techniques
Tabor, A., & Alfirević, Ž. (2009) · Fetal Diagnosis and Therapy · doi:10.1159/000271995 · Cited by 398
Oesophageal atresia: prevalence, prenatal diagnosis and associated anomalies in 23 European regions
Pedersen, R. N., Calzolari, E., Husby, S., Garne, E., & EUROCAT Working group* (2012) · Archives of Disease in Childhood · doi:10.1136/archdischild-2011-300597 · Cited by 389
Self-citation
Metadata
- Authors
- Boyd, P., DeVigan, C., Khoshnood, B., Loane, M., Garne, E., Dolk, H., & EUROCAT working group
- Affiliations
- University of Oxford (GB)
- Inserm (FR)
- University of Ulster (GB)
- Kolding Hospital (DK)
- Corresponding author
- Boyd, PA
- Venue
- BJOG: An International Journal of Obstetrics & Gynaecology
- Publisher
- Wiley
- Published
- 2008-04-09
- Volume
- 115
- Issue
- 6
- Pages
- 689-696
- ISSN
- 0306-5456 (ISSN-L)
- 1470-0328
- 1471-0528
- PMC
- PMC2344123
- OpenAlex
- W2015487852
- Cited by
- 335
- References
- 19
- Citations by year
- 2026: 6 · 2025: 10 · 2024: 9 · 2023: 15 · 2022: 17 · 2021: 16 · 2020: 20 · 2019: 16 · 2018: 18 · 2017: 19 · 2016: 16 · 2015: 23 · 2014: 31 · 2013: 31 · 2012: 25
- FWCI
- 18.64
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- BJOG An International Journal of Obstetrics & Gynaecology (publishedVersion)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- SERVAL (Université de Lausanne) (publishedVersion, other-oa)
- IRIS (submittedVersion)
- University of Groningen research database (University of Groningen / Centre for Information Technology) (submittedVersion, cc-by)
- DigitalGeorgetown (Georgetown University Library) (submittedVersion)
- University of Southern Denmark Research Portal (University of Southern Denmark) (submittedVersion)
- Funders
- National Institute for Health and Care Research
- European Commission
- Topics
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Prenatal Screening and Diagnostics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Down syndrome and intellectual disability research
- Health Sciences › Medicine › Surgery › Congenital Anomalies and Fetal Surgery
- Keywords
- Down syndrome, neural tube defects, prenatal diagnosis, first-trimester screening, gestational age limits, EUROCAT, country variation, Europe
- MeSH terms
- Abortion, Induced, Down Syndrome, Europe, Female, Genetic Testing, Gestational Age, Health Policy, Humans, Neural Tube Defects, Pregnancy, Pregnancy Trimesters, Prenatal Diagnosis, Surveys and Questionnaires, Ultrasonography, Prenatal
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
